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Some 19 000 children under the age of 5 years die 
each and every day, with 5500 of these deaths caused 
by pneumonia and diarrhoea.1  These are not mere 
statistics. 2 million young lives are lost each year from 
these two eminently preventable causes of death.2 This 
situation is completely unacceptable. Despite the fact 
that the basic elements needed to reduce childhood 
deaths from pneumonia and diarrhoea are well known 
and of low cost, current coverage is appallingly low.
We welcome the Lancet Series on C hildhood Pneu-
monia and Diarrhoea.1–4 The Series provides the evidence 
base to make the case that ending preventable child 
deaths from pneumonia and diarrhoea within the next 
12 years is ambitious but achievable and necessary. 
Momentum to reduce child mortality continues to 
build, and it is imperative for the world’s children that 
we take advantage of this opportunity.
As we approach the 1000-day mark before the 
Millennium Development Goal deadline, a raft of inter-
connected initiatives provides a platform to accelerate 
progress. The UN Secretary-General’s widely endorsed 
Global Strategy for Women’s and Children’s Health 
aims to save 16 million lives through a “continuum 
of care” approach; a Global Vaccine Action Plan is 
working towards universal access to immunisation 
by 2020; more than 170 countries have signed on to 
A Promise Renewed, the call to action spearheaded by 
the Governments of Ethiopia and India, UNICEF, and 
USAID to end all preventable child deaths by 2035; 
and the UN Commission on Life-Saving Commodities for 
Women and Children is helping to improve access to 
priority medicines.
In this context, it is critical to intensify eﬀ orts to tackle 
pneumonia and diarrhoea—the two biggest killers of 
children younger than 5 years after the newborn period, 
which account for about 29% of all under-5 deaths.1 A 
new WHO/UNICEF Integrated Global Action Plan for the 
Prevention and Control of Pneumonia and Diarrhoea5 aims 
to help countries meet this goal by establishing healthy 
environments to protect children from pneumonia and 
diarrhoea and by increasing access to cost-eﬀ ective 
interventions for both prevention and treatment. 
The Integrated Plan builds upon two previous plans 
from 2009: the Global Action Plan for the Prevention 
and Control of Pneumonia6 and Why Children are Still 
Dying and What Can be Done,7 a seven-point plan for 
comprehensive diarrhoea control. We have encouraged 
the use of cost-eﬀ ective prevention—eg, exclusive 
breastfeeding, vac cines, and access to clean water—and 
treatment with simple, inexpen sive antibiotics, oral 
rehydration salts, and zinc. Now we must help countries 
unplug the bottlenecks that are keeping these services 
from the children who need them.
Children who are poor, hungry, and living in remote 
areas are most likely to suﬀ er from these “forgotten 
killers”, and the burden that pneumonia and diarrhoea 
places on their families and on health systems aggra-
vates existing inequalities. Identifying the children at 






See Series pages 1487 and 1499
See Series Lancet 2013; 
381: 1487 and 1499
 7 Centers for Disease Control and Prevention. National immunization survey 
(NIS)—children (19–35 months). 2012. http://www.cdc.gov/vaccines/ 
stats-surv/nis/default.htm#nis (accessed April 19, 2013).
 8 Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous 
measles, mumps, and rubella from Finland by a 12-year, two-dose 
vaccination program. N Engl J Med 1994; 331: 1397–402.
 9 Haverkate M, D’Ancona F, Giambi C, et al. Mandatory and recommended 
vaccination in the EU, Iceland and Norway: results of the VENICE 2010 
survey on the ways of implementing national vaccination programmes. 
Euro Surveill 2012; 17: pii 20183.
 10 Salmon DA, Teret SP, MacIntyre CR, Salisbury D, Burgess MA, Halsey NA. 
Compulsory vaccination and conscientious or philosophical exemptions: 
past, present, and future. Lancet 2006; 367: 436–42.
 11 Samad L, Butler N, Peckham C, Bedford H. Incomplete immunisation 
uptake in infancy: maternal reasons. Vaccine 2006; 24: 6823–29.
 12 Samad L, Tate AR, Dezateux C, Peckham C, Butler N, Bedford H. Diﬀ erences 
in risk factors for partial and no immunisation in the ﬁ rst year of life: 
prospective cohort study. BMJ 2006; 332: 1312–13.
 13 Omer SB, Salmon DA, Orenstein WA, deHart MP, Halsey N. Vaccine refusal, 
mandatory immunization, and the risks of vaccine-preventable diseases. 
N Engl J Med 2009; 360: 1981–88.
 14 Benin AL, Wisler-Scher DJ, Colson E, Shapiro ED, Holmboe ES. Qualitative 
analysis of mothers’ decision-making about vaccines for infants: 
the importance of trust. Pediatrics 2006; 117: 1532–41.
 15 Petrovic M, Roberts R, Ramsay M. Second dose of measles, mumps, and 
rubella vaccine: questionnaire survey of health professionals. BMJ 2001; 
322: 82.
16 Health Protection Agency/Public Health England. Completed primary 
courses at two years of age: England and Wales, 1966–1977, England only 
1978 onwards. http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/
HPAweb_C/1195733819251 (accessed April 19, 2013).
Comment
www.thelancet.com   Vol 381   April 27, 2013 1437
greatest risk, who are the hardest to reach and the most 
neglected, and targeting them with interventions that 
are proven to work will close the gap and end these 
entirely preventable deaths.
Better coordination and integration are key to tack-
ling pneumonia and diarrhoea. The determinants that 
underlie these diseases are often the same. The chil-
dren at risk of diarrhoea are the same ones at risk of 
pneumonia. The strategies for prevention are similar, 
and the places where systems need strengthening to 
deliver services in communities, clinics, and hospitals 
are also common to both diseases. The Integrated Plan 
makes a strong case for more eﬃ  cient integration 
and identiﬁ es key steps to be taken. It will help 
countries to analyse local data, act on the results, and 
monitor progress towards clear, achievable goals. 
This requires a concerted eﬀ ort to use a systematic 
approach of sharpening evidence-based planning and 
implementation at all levels, and ensuring eﬀ ective 
systems of monitoring and account ability for results, 
within existing frameworks such as the Commission on 
Information and Accountability for Women’s and Children’s 
Health and Countdown to 2015.
We must also build on lessons learned and the good 
practices and innovations that some countries have 
been applying, which include strengthening primary 
care; removing ﬁ nancial barriers to access; expanding the 
role of non-governmental providers; establishing public-
private partnerships; and making use of new mobile 
technologies to achieve sustainable, quality services.
This is not a job for the health sector alone. Successful 
implementation of the Integrated Plan requires engage-
ment of families, health-care providers, and key actors 
in water and sanitation. There must also be strong 
cooperation among UN agencies, national governments, 
and the private sector. And it must begin today.
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Fears about development of Guillain-Barré syndrome 
(GBS) after inﬂ uenza vaccination have hampered indi-
vidual and population-level vaccine coverage rates. Un-
certain ties began with the 1976 H1N1 swine inﬂ uenza 
vaccine programme, which saw an estimated relative risk 
of GBS of 7–8 after vaccination,1 although the attribu-
table risk was probably lower.2 Regardless, the Institute 
of Medicine stated in 2004 that evidence favours a 
causal relation between the 1976 H1N1 inﬂ uenza 
vaccine and GBS3 but in 2011 concluded the evidence 
was inadequate for seasonal vaccines. “While the weight 
of epidemiological evidence does not support a causal 
link between inﬂ uenza vaccinations evaluated over the 
last 30 years, an association cannot be conﬁ dently ruled 
out.”4 If GBS is associated with inﬂ uenza vaccine, the risk 
is possibly so small that it can neither be conﬁ dently nor 
consistently detected and measured.
In The Lancet, Daniel Salmon and colleagues report 
a meta-analysis of safety data for inﬂ uenza A (H1N1) 
2009 monovalent inactivated vaccines in the USA.5 
23 million vaccinated individuals of all ages were 
included, from six diﬀ erent surveillance systems. 
Inﬂ uenza vaccine and Guillain-Barré syndrome: making 
informed decisions
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